ROVATI, LUCIO CLAUDIO,D'AMATO, MASSIMO MARIA,MENGS, ULRICH,POHL, RALF-TORSTEN,FERENCI, PETER
申请号：
CA2703834
公开号：
CA2703834C
申请日:
2008.11.14
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The invention relates to the use of a silibinin component for the productionof a medicament that is adapted forparenteral administration for the treatment of viral hepatitis, preferably ofhepatitis B or C, in particular for the reduction of the virusload. The medicament preferably contains no silidianin and/or no silichristinand/or no isosilibinin.
